Communiqués Renovaro Inc. Börse Stuttgart

Actions

2Q5

US29350E1047

Marché Fermé - Börse Stuttgart Autres places de cotation 16:14:09 28/06/2024			Varia. 5j.	Varia. 1 janv.
1,362 ^EUR	-5,68%		+11,09%	-56,62%

14/06	Renovaro annonce que des investisseurs se sont engagés à verser 10 millions de dollars de fonds propres supplémentaires	MT
24/05	Renovaro et le Centre de cancérologie de l'UMC d'Amsterdam prévoient de former une coentreprise pour l'immunothérapie du cancer	MT

Communiqués

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

Renovaro, Inc. Announces $10 million in Equity Committed	14/06	GL
Renovaro Inc. and Amsterdam UMC Cancer Center Poised to Advance Cancer Immunotherapy	24/05	GL
Renovaro : Material Event - Form 8-K	02/05	PU
Transforming Cancer Detection: RenovaroCube Introduces Flamingo, a novel AI model based on Fragmentomics	30/04	GL
Transforming Cancer Detection: RenovaroCube Introduces Flamingo, a novel AI model based on Fragmentomics	30/04	AQ
RENOVARO - RENOVAROCUBE TO ACQUIRE 100% OWNERSHIP OF CYCLOMICS, REINFORCING CUTTING-EDGE CANCER DIAGNOSTICS PARTNERSHIP	25/04	AQ
RenovaroCube to Acquire 100% Ownership of Cyclomics, Reinforcing Cutting-Edge Cancer Diagnostics Partnership	24/04	GL
Renovaro Inc. Proudly Announces the Appointment Of Professor Dr. Geert Kazemier as the Chairman of its Scientific Advisory Board, A Move That Heralds a New Era of Innovation and Progress in its Mission to Reshape Cancer Screening, Diagnosis, and Patient Care	18/04	GL
Pomerantz Law Firm Investigates Claims On Behalf of Investors of Renovaro Biosciences Inc. - RENB	12/03	PR
Pomerantz Law Firm Investigates Claims On Behalf of Investors of Renovaro Biosciences Inc. - RENB	03/03	PR
ROSEN, LEADING INVESTOR COUNSEL, Encourages Renovaro Biosciences Inc. Investors to Inquire About Securities Class Action Investigation - RENB	25/02	PR
Pomerantz Law Firm Investigates Claims On Behalf of Investors of Renovaro Biosciences Inc. - RENB	24/02	PR
ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Renovaro Biosciences Inc. Investors to Inquire About Securities Class Action Investigation - RENB	17/02	PR
Pomerantz Law Firm Investigates Claims On Behalf of Investors of Renovaro Biosciences Inc. - RENB	16/02	PR
Cutting Edge AI Company GEDiCube and Cyclomics sign binding LOI to join forces and position themselves at the forefront of the global liquid biopsy marketplace	15/02	GL
Statement of Renovaro Inc	14/02	GL
ROSEN, A LEADING NATIONAL FIRM, Encourages Renovaro Biosciences Inc. Investors to Inquire About Securities Class Action Investigation – RENB	13/02	BU
Cutting Edge AI Company GEDiCube and Cyclomics sign binding LOI to join forces and position themselves at the forefront of the global liquid biopsy marketplace	13/02	GL
AI Pioneer GEDi Cube and Biotech Innovator Renovaro Biosciences Combine Forces to Accelerate Personalized Medicine	13/02	GL
Renovaro Biosciences Announces Results of Special Meeting of Shareholders	25/01	GL

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Communiqués Renovaro Inc. Börse Stuttgart

Actions

2Q5

US29350E1047

Communiqués

Filtres